Rothschild Investment LLC Dyne Therapeutics, Inc. Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q3 2024
A detailed history of Rothschild Investment LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 90 shares of DYN stock, worth $2,634. This represents 0.0% of its overall portfolio holdings.
Number of Shares
90
Previous 35
157.14%
Holding current value
$2,634
Previous $1.24 Million
161.78%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DYN
# of Institutions
203Shares Held
105MCall Options Held
82.7KPut Options Held
24.8K-
Atlas Venture Life Science Advisors, LLC8.02MShares$235 Million37.7% of portfolio
-
Fcpm Iii Services B.V. Naarden, P77.85MShares$230 Million40.83% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$216 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.39MShares$187 Million3.76% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$177 Million3.22% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.52B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...